France· FR:62938313
CIPROFIBRATE ARROW 100 mg, gélule
A ciprofibrate product containing ciprofibrate, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Ciprofibrate is registered in 5 of 19 countries.
Countries holding a registration under ATC C10AB08 (ciprofibrate), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 3 of them publish a price we can compare per daily dose
Ciprofibrate · ATC C10AB08
5 / 19 countries
- Belgiumprice
- Franceprice
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CIPROFIBRATE
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- C10AB08
- ATC class
- Ciprofibrate
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400938335682plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 gélule(s)EUR 3.4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciprofibrate in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCiprofibrate Amdipharm 100 mgAmdipharm
- PolandLipanorSanofi Winthrop Industrie
- United KingdomCiprofibrate 100mg tabletsCST Pharma Ltd
- NetherlandsModalim, tabletten 100 mgSanofi B.V.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Bulgaria · Липанор
- United Kingdom (Northern Ireland) · Ciprofibrate Accord-Uk, Ciprofibrate Zentiva
- Netherlands · Ciprofibraat Amdipharm, Modalim
- Poland · Lipanor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1aa27ed-9576-4e85-a291-d30cbf0f2a3e GET /v1/drugs/d1aa27ed-9576-4e85-a291-d30cbf0f2a3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62938313",
"date_amm": "2004-06-03",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CIPROFIBRATE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about ciprofibrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.